Focal adhesion kinase (FAK) localizes to focal adhesions and is overexpressed in many cancers. FAK can also translocate to the nucleus, where it binds to, and regulates, several transcription factors, including MBD2, p53 and IL-33, to control gene expression by unknown mechanisms. We have used ATAC-seq to reveal that FAK controls chromatin accessibility at a subset of regulated genes. Integration of ATAC-seq and RNA-seq data showed that FAK-dependent chromatin accessibility is linked to differential gene expression, including of the FAK-regulated cytokine and transcriptional regulator interleukin-33 (Il33), which controls anti-tumor immunity. Analysis of the accessibility peaks on the Il33 gene promoter/enhancer regions revealed sequences f...
Focal adhesion kinase (FAK) is a ubiquitous expressed protein tyrosine kinase. In growing cells, FAK...
The death domain containing TNF receptor 6 (CD95/Fas) is a direct target for the NF-kB transcription...
Decreased Fas expression during tumor progression often results in a loss of Fas-ligand (FasL)-media...
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase, commonly overexpressed in cancer tha...
Focal adhesion kinase (FAK) mediates tumor cell-intrinsic behaviors that promote tumor growth and me...
SummaryFocal adhesion kinase (FAK) promotes anti-tumor immune evasion. Specifically, the kinase acti...
Cooperation between STAT3 and c-Jun results in suppression of Fas Receptor (FasR) transcription, whi...
Focal adhesion kinase (FAK) promotes anti-tumor immune evasion. Specifically, the kinase activity of...
Focal adhesion kinase (FAK) is a protein tyrosine kinase (PTK) crucial in regulation of cell migrati...
AbstractThe sequence of genomic alterations acquired by cancer cells during tumor progression and me...
Focal adhesion kinase (FAK) is a non-receptor tyosine kinase present in cell-ECM focal adhesions. As...
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is elevated in a variety of human ...
Cancer-associated fibroblasts (CAFs) are important for tumor initiation and promotion. CSL, a transc...
Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of tr...
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed and activated in both a...
Focal adhesion kinase (FAK) is a ubiquitous expressed protein tyrosine kinase. In growing cells, FAK...
The death domain containing TNF receptor 6 (CD95/Fas) is a direct target for the NF-kB transcription...
Decreased Fas expression during tumor progression often results in a loss of Fas-ligand (FasL)-media...
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase, commonly overexpressed in cancer tha...
Focal adhesion kinase (FAK) mediates tumor cell-intrinsic behaviors that promote tumor growth and me...
SummaryFocal adhesion kinase (FAK) promotes anti-tumor immune evasion. Specifically, the kinase acti...
Cooperation between STAT3 and c-Jun results in suppression of Fas Receptor (FasR) transcription, whi...
Focal adhesion kinase (FAK) promotes anti-tumor immune evasion. Specifically, the kinase activity of...
Focal adhesion kinase (FAK) is a protein tyrosine kinase (PTK) crucial in regulation of cell migrati...
AbstractThe sequence of genomic alterations acquired by cancer cells during tumor progression and me...
Focal adhesion kinase (FAK) is a non-receptor tyosine kinase present in cell-ECM focal adhesions. As...
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that is elevated in a variety of human ...
Cancer-associated fibroblasts (CAFs) are important for tumor initiation and promotion. CSL, a transc...
Genomic enhancers regulate spatio-temporal gene expression by recruiting specific combinations of tr...
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed and activated in both a...
Focal adhesion kinase (FAK) is a ubiquitous expressed protein tyrosine kinase. In growing cells, FAK...
The death domain containing TNF receptor 6 (CD95/Fas) is a direct target for the NF-kB transcription...
Decreased Fas expression during tumor progression often results in a loss of Fas-ligand (FasL)-media...